Whittier Trust Co. of Nevada Inc. Has $58,000 Stock Position in Molina Healthcare, Inc. (NYSE:MOH)

Whittier Trust Co. of Nevada Inc. increased its holdings in shares of Molina Healthcare, Inc. (NYSE:MOH) by 337.0% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 201 shares of the company’s stock after acquiring an additional 155 shares during the quarter. Whittier Trust Co. of Nevada Inc.’s holdings in Molina Healthcare were worth $58,000 as of its most recent SEC filing.

Other institutional investors have also made changes to their positions in the company. True Wealth Design LLC increased its holdings in shares of Molina Healthcare by 2,500.0% during the 3rd quarter. True Wealth Design LLC now owns 104 shares of the company’s stock worth $36,000 after acquiring an additional 100 shares during the last quarter. Versant Capital Management Inc grew its holdings in Molina Healthcare by 83.1% in the 4th quarter. Versant Capital Management Inc now owns 163 shares of the company’s stock valued at $47,000 after buying an additional 74 shares in the last quarter. Wingate Wealth Advisors Inc. acquired a new position in Molina Healthcare in the 4th quarter valued at $52,000. EverSource Wealth Advisors LLC grew its holdings in Molina Healthcare by 81.5% in the 4th quarter. EverSource Wealth Advisors LLC now owns 196 shares of the company’s stock valued at $57,000 after buying an additional 88 shares in the last quarter. Finally, Harvest Fund Management Co. Ltd grew its holdings in Molina Healthcare by 895.0% in the 4th quarter. Harvest Fund Management Co. Ltd now owns 199 shares of the company’s stock valued at $58,000 after buying an additional 179 shares in the last quarter. 98.50% of the stock is owned by institutional investors and hedge funds.

Insiders Place Their Bets

In other Molina Healthcare news, Director Steven J. Orlando sold 1,000 shares of the company’s stock in a transaction dated Monday, March 3rd. The stock was sold at an average price of $301.33, for a total value of $301,330.00. Following the completion of the transaction, the director now owns 17,375 shares of the company’s stock, valued at $5,235,608.75. This represents a 5.44 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Insiders own 1.10% of the company’s stock.

Molina Healthcare Price Performance

Shares of MOH stock opened at $309.85 on Monday. The company has a quick ratio of 1.62, a current ratio of 1.62 and a debt-to-equity ratio of 0.69. Molina Healthcare, Inc. has a twelve month low of $262.32 and a twelve month high of $423.92. The company has a market cap of $16.95 billion, a P/E ratio of 15.17, a P/E/G ratio of 1.06 and a beta of 0.56. The business has a fifty day simple moving average of $299.99 and a 200 day simple moving average of $309.21.

Molina Healthcare (NYSE:MOH) last announced its quarterly earnings data on Wednesday, February 5th. The company reported $5.05 earnings per share for the quarter, missing the consensus estimate of $5.74 by ($0.69). Molina Healthcare had a return on equity of 28.13% and a net margin of 2.90%. On average, sell-side analysts forecast that Molina Healthcare, Inc. will post 24.4 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

A number of research analysts have commented on MOH shares. Wells Fargo & Company raised Molina Healthcare from an “equal weight” rating to an “overweight” rating and upped their price objective for the company from $295.00 to $372.00 in a report on Wednesday, March 5th. Truist Financial cut their target price on Molina Healthcare from $370.00 to $340.00 and set a “buy” rating for the company in a research report on Wednesday, February 19th. Stephens reiterated an “equal weight” rating and set a $345.00 target price on shares of Molina Healthcare in a research report on Thursday, February 6th. JPMorgan Chase & Co. reiterated a “neutral” rating and set a $350.00 target price (down from $378.00) on shares of Molina Healthcare in a research report on Tuesday, December 17th. Finally, Barclays cut their target price on Molina Healthcare from $372.00 to $339.00 and set an “equal weight” rating for the company in a research report on Friday, February 7th. One analyst has rated the stock with a sell rating, seven have assigned a hold rating, six have issued a buy rating and one has issued a strong buy rating to the company’s stock. According to data from MarketBeat.com, the company presently has an average rating of “Hold” and a consensus target price of $355.69.

Molina Healthcare Company Profile

Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.